Search results
Coronary Bioresorbable Scaffolds
Author(s):
Bill D Gogas
,
Jun-Jie Zhang
,
Shao-Liang Chen
Added:
3 years ago
Article
Author(s):
Abdulrahman Almoghairi
,
Nayef Al-Asiri
,
Khalid Al Johani
,
et al
Added:
8 months ago
Author(s):
Alexander G Truesdell
,
Matheen A Khuddus
,
Sara C Martinez
,
et al
Added:
3 years ago
“When you fail to prepare, you’re preparing to fail.”
– Coach John Wooden
Ongoing technological and procedural innovations increasingly permit the safe and effective performance of ever more high-risk and complex percutaneous coronary interventions (PCI) in the modern cardiac catheterization laboratory. Anatomic characteristics of higher risk include unprotected distal left main stenosis,…
View more
Author(s):
On Topaz
Added:
3 years ago
The last three years have seen the application of percutaneous excimer laser atherectomy in patients sustaining acute myocardial infarction (AMI) gaining momentum. Current efforts in the US are concentrated toward identification of the best technologies for efficacious restoration of flow in the infarct-related vessel and toward shortening the time lag between the presentation of AMI patients to…
View more
Author(s):
Angelos Tsipis
,
Evdokia Petropoulou
Added:
1 year ago
Author(s):
William Fearon
Added:
2 years ago
In this short interview, Dr William F Fearon (Stanford University School of Medicine, US) discusses the findings from the FAME3 trial. This multicenter, international, randomized, controlled noninferiority trial investigated whether fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) in patients with multivessel coronary artery disease (CAD) will result in similar…
View more
Author(s):
On Topaz
Added:
3 years ago
The last three years have seen the application of percutaneous excimer laser atherectomy in patients sustaining acute myocardial infarction (AMI) gaining momentum. Current efforts in the US are concentrated toward identification of the best technologies for efficacious restoration of flow in the infarct-related vessel1 and toward shortening the time lag between the presentation of AMI patients to…
View more
Author(s):
Marc Sirol
Added:
3 years ago
Atherosclerosis and its thrombotic complications are the first cause of mortality and morbidity in industrialized countries. Furthermore, despite pharmacological intervention and lifestyle changes, cardiovascular disease (CVD) continues to be the principal cause of death in the US.1 Despite great advances in the understanding of the initiation and progression of atherosclerosis and its risk…
View more
Author(s):
Marc Sirol
Added:
3 years ago
Atherosclerosis and its thrombotic complications are the first cause of mortality and morbidity in industrialized countries. Furthermore, despite pharmacological intervention and lifestyle changes, cardiovascular disease (CVD) continues to be the principal cause of death in the US. Despite great advances in the understanding of the initiation and progression of atherosclerosis and its risk…
View more
Stephen W Lee
Author